Table 1.
Characteristic | Overall (n=651) | Glomerular Disease (n=195) | Nonglomerular Disease (n=456) |
---|---|---|---|
Age, yr | 11 [8–15] | 14 [11–16] | 10 [7–14] |
Sex (male) | 404 (62) | 106 (54) | 298 (65) |
Black race | 131 (20) | 59 (30) | 72 (16) |
Hispanic ethnicity | 86 (13) | 27 (14) | 59 (13) |
Premature birth (<36 wk) | 74 (12) | 21 (11) | 53 (12) |
eGFR | 53 [40–67] | 62 [45–78] | 50 [38–62] |
Time with CKD, yr | 8.2 [3.9–12.4] | 3.4 [1.3–7.6] | 9.5 [6.3–13.2] |
Hypertension | 117 (18) | 30 (15) | 87 (19) |
BUN | 24 [18–32] | 23 [17–30] | 25 [18–33] |
Serum albumin level | 4.4 [4.1–4.6] | 4.2 [3.8–4.5] | 4.4 [4.2–4.6] |
Hemoglobin level | 12.7 [11.7–13.7] | 12.3 [11.5–13.5] | 12.8 [11.8–13.7] |
Urine protein/creatinine, mg/g | 0.32 [0.12–0.94] | 0.61 [0.21–1.76] | 0.24 [0.11–0.69] |
Treatment with RAAS inhibitor | 370 (57) | 159 (82) | 211 (46) |
Hypertension is defined as a systolic or diastolic BP ≥95 percentile for age, height, and sex. Sample size differs due to missing data: time with CKD (n=640), hemoglobin level (n=639), Hispanic ethnicity (n=643), premature (n=627), and serum albumin level (n=649). Median [IQR] or frequency (percentage, %). RAAS, renin-angiotensin-aldosterone system.